Hypoglycemia and Pancreatic Islet Cell Disorders

Goldman's Cecil Medicine: Twenty Fourth Edition

Volumn 2, Issue , 2012, Pages 1499-1505

  Vella, Adrian ^a   Rizza, Robert A ^a   John Service, F ^a,b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867764438     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1604-7.00238-4     Document Type: Chapter

References (5)

1. Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009, 94:709-728.
2. Druce MR, Muthuppalaniappan VM, O'Leary B, et al. Diagnosis and localization of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterization. Eur J Endocrinol 2010, 162:971-978. Of 36 patients, 16 were localized by CT and 21 by MRI.
3. Ekeblad S Islet cell tumours. Adv Exp Med Biol 2010, 654:771-789. Overview of pancreatic endocrine tumors that can cause hormonal symptoms by over-secretion.
4. Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab 2009, 94:1069-1073. Review of changes in the presentation, diagnosis, and radiological evaluation of patients with surgically confirmed insulinoma at the Mayo Clinic over two decades.
5. Watts AG, Donovan CM Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation. Front Neuroendocrinol 2010, 31:32-43. Review of the organization of the neural systems that are engaged by glucosensing mechanisms when blood glucose concentrations fall to levels that pose a physiological threat.